Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05166785
Other study ID # 21-01039
Secondary ID 1R01DK127916-01A
Status Recruiting
Phase N/A
First received
Last updated
Start date October 5, 2022
Est. completion date November 2026

Study information

Verified date October 2023
Source NYU Langone Health
Contact Taj Adams
Phone 646-501-4681
Email Bridgestudy@nyulangone.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Over 24 million Americans are over 65 years and have prediabetes. Prediabetes can be addressed using a public health approach: among the 20% of participants in the Diabetes Prevention Program (DPP) who were ages 60 and over, the diet and physical activity intervention conferred a 71% risk reduction of diabetes after an average follow-up of 3 years. The population of older adults is projected to more than double from 52.5 million in 2019 to ~100 million by 2060, and if projections hold, about half (48.3%) will have prediabetes. The proposed hybrid effectiveness implementation type 1 design will compare a DPP program Tailored for Older Adults and delivered via Telehealth (DPP-TOAT arm) to an in person DPP tailored for older adults (DPP arm) using a randomized, controlled trial design (n=230). The preliminary data suggests DPP-TOAT is a feasible and acceptable way to deliver the DPP to older adults, and this will be the first study to compare the effectiveness and implementation of two strategies (telehealth versus in-person) to deliver a tailored DPP for the unique needs of the growing population of older adults.


Description:

Eligible patients will be recruited through electronic health records (Epic and MyChart) and randomized to the 12-month DPP-TOAT or the in-person DPP program. Primary effectiveness outcome will be 6-month weight loss and implementation outcome will be attendance. A pragmatic approach will be used in order to inform future studies conducted in community-based and rural settings. Findings will inform best practices in the delivery of an evidence-based intervention that could reach the 30+ million adults aged 65 and over with prediabetes.


Recruitment information / eligibility

Status Recruiting
Enrollment 230
Est. completion date November 2026
Est. primary completion date May 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 65 Years and older
Eligibility Inclusion Criteria: - Men and women aged 65 years and older - Diagnosis of pre-diabetes (A1c between 5.7-6.4%, fasting glucose between 100-125 mg/dL, or oral glucose tolerance test between 140-199 mg/dL within past 12 months) - BMI of greater than or equal to 30 - English-speaking - Under the care of a Primary care provider (PCP) in the NYU Langone Health system - Able to travel to NYU Langone for in-person evaluations - Access to a telephone - Informed consent Exclusion Criteria: - Prevalent diabetes or end-stage renal disease - Prior participation in the Diabetes Prevention Program - A documented current history of active psychosis or other cognitive issues via International Classification of Diseases (ICD) -10 codes - Taking FDA-approved weight loss medications - PCP stating that patient should not participate - Inability to communicate due to severe, uncorrectable hearing loss or speech disorder - Severe visual impairment that precludes completion of assessments and/or intervention

Study Design


Related Conditions & MeSH terms


Intervention

Other:
DPP Tailored for Older Adults and delivered via Telehealth
Diabetes Prevention Program (DPP) Tailored for Older Adults and delivered via Telehealth (DPP-TOAT) will be composed of 16 60-minute weekly sessions followed by six 60-minute monthly support sessions
In-Person Diabetes Prevention Program (DPP)
Diabetes Prevention Program (DPP) is composed of 16 60-minute weekly sessions followed by six 60-minute monthly support sessions over 12 months in person approved by the Centers for Disease Control and Prevention (CDC)

Locations

Country Name City State
United States NYU Langone Health New York New York

Sponsors (2)

Lead Sponsor Collaborator
NYU Langone Health National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in weight in participants in DPP-TOAT is similar to those in In-Person DPP In-person outcome assessment visits at the New York University Langone research clinic to measure weight at baseline, 6, and 12 months among all randomized participants Baseline visit, 6 months visit, 12 month visit
Primary Changes in HbA1c in participants in DPP-TOAT is similar to those in In-Person DPP In-person outcome assessment visits at New York University Langone research clinic to measure glycemia at baseline, 6, and 12 months among all randomized participants Baseline visit, 6 months visit, 12 month visit
Secondary Adherence to the DPP-TOAT is greater than the in-person DPP This will be measured by the number of group sessions completed by each participant. Baseline visit, 6 months visit, 12 month visit
See also
  Status Clinical Trial Phase
Recruiting NCT05052918 - The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes N/A
Completed NCT03714646 - Beta Glucan and Acetate Production N/A
Completed NCT03377244 - Healthy Body Healthy Souls in the Marshallese Population N/A
Completed NCT04427982 - Dance and Diabetes/Prediabetes Self-Management N/A
Recruiting NCT05008276 - Puberty, Diabetes, and the Kidneys, When Eustress Becomes Distress (PANTHER Study)
Completed NCT03480022 - Liraglutide 3mg (Saxenda) on Weight, Body Composition, Hormonal and Metabolic Parameters in Obese Women With PCOS Phase 3
Active, not recruiting NCT05290233 - Time Restricted Eating Plus Exercise for Weight Management N/A
Withdrawn NCT05726409 - Mobile Application to Create Healthy Food Preparation Habits for Patients With Diabetes and Prediabetes N/A
Completed NCT02834078 - Effect of BGG on Glucose Metabolism and Other Markers of Metabolic Syndrome N/A
Completed NCT04902326 - Behavioral Economics and Self-Determination Theory to Change Diabetes Risk (BEST Change) N/A
Recruiting NCT04168372 - Fructose: Substrate, Stimulus, or Both? N/A
Completed NCT03272074 - Egg Consumption and Glycemic Control in Individuals With Pre- and Type II-diabetes N/A
Not yet recruiting NCT05939349 - A Prescription for Health Equity: A Healthcare Provider-based Produce Prescription Program for People With Prediabetes and Type 2 Diabetes N/A
Completed NCT04978376 - TRE With Physical Activity for Weight Management N/A
Recruiting NCT03997656 - A Digital Therapy for Diabetes Prevention Among Overweight Adults in Terengganu, Malaysia N/A
Completed NCT01729078 - Dietary Interventions in Prediabetes N/A
Completed NCT04507685 - Asian Indian Prediabetes Study N/A
Completed NCT03292315 - Once Weekly GLP-1 in Persons With Spinal Cord Injury Phase 4
Active, not recruiting NCT05353790 - Dietary Exchanges With Avocado and Mango in Pre-diabetes N/A
Active, not recruiting NCT03804892 - Can Brisk Walking Combined With Ingestion of a Lipid-lowering Drug Improve Fat Metabolism in Muscle? N/A